Authors:
Avis, I
Hong, SH
Martinez, A
Moody, T
Choi, YH
Trepel, J
Das, R
Jett, M
Mulshine, JL
Citation: I. Avis et al., Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions, FASEB J, 15(9), 2001, pp. NIL_277-NIL_306
Authors:
Zhou, J
Allred, DC
Avis, I
Martinez, A
Vos, MD
Smith, L
Treston, AM
Mulshine, JL
Citation: J. Zhou et al., Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer, BREAST CANC, 66(3), 2001, pp. 217-224
Authors:
Wang, DL
Marko, M
Dahl, AR
Engelke, KS
Placke, ME
Imondi, AR
Mulshine, JL
De Luca, LM
Citation: Dl. Wang et al., Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors, CLIN CANC R, 6(9), 2000, pp. 3636-3645
Authors:
Dahl, AR
Grossi, IM
Houchens, DP
Scovell, LJ
Placke, ME
Imondi, AR
Stoner, GD
De Luca, LM
Wang, DL
Mulshine, JL
Citation: Ar. Dahl et al., Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: A pilot study, CLIN CANC R, 6(8), 2000, pp. 3015-3024
Citation: Ms. Tockman et Jl. Mulshine, Correspondence re: M. S. Tockman et al., Prospective detection of preclinical lung cancer: Results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res., 3 : 2237-2246, 1997. Reply, CLIN CANC R, 6(4), 2000, pp. 1602-1603
Authors:
Man, YG
Martinez, A
Avis, IM
Hong, SH
Cuttitta, F
Venzon, DJ
Mulshine, JL
Citation: Yg. Man et al., Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations, AM J RESP C, 23(5), 2000, pp. 636-645
Authors:
Hong, SH
Ondrey, FG
Avis, IM
Chen, Z
Loukinova, E
Cavanaugh, PF
Van Waes, C
Mulshine, JL
Citation: Sh. Hong et al., Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?, FASEB J, 14(11), 2000, pp. 1499-1507
Authors:
Mulshine, JL
De Luca, LM
Dedrick, RL
Tockman, MS
Webster, R
Placke, ME
Citation: Jl. Mulshine et al., Considerations in developing successful, population-based molecular screening and prevention of lung cancer, CANCER, 89(11), 2000, pp. 2465-2467
Authors:
Chaudhry, A
Carrasquillo, JA
Avis, IL
Shuke, N
Reynolds, JC
Bartholomew, R
Larson, SM
Cuttitta, F
Johnson, BE
Mulshine, JL
Citation: A. Chaudhry et al., Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer, CLIN CANC R, 5(11), 1999, pp. 3385-3393
Authors:
Iwai, N
Martinez, A
Miller, MJ
Vos, M
Mulshine, JL
Treston, AM
Citation: N. Iwai et al., Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors, LUNG CANC, 23(3), 1999, pp. 209-222
Authors:
Hong, SH
Avis, I
Vos, MD
Martinez, A
Treston, AM
Mulshine, JL
Citation: Sh. Hong et al., Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors, CANCER RES, 59(9), 1999, pp. 2223-2228